SANTEN PHARMACEUTICAL CO financial statements, including revenue, expenses, profit, and loss

The total revenue of 4536 for the last quarter is 74.77 B JPY, and it's 5.51% lower compared to the previous quarter. The net income of Q1 24 is 10.63 B JPY.